GoodRx Holdings, Inc. Class A GDRX 深 滬
等待開盤 05-20 09:30:00 美东时间
2.52
+0.020
+0.80%
華盛通- 最 高2.545
- 今 開2.50
- 成交量 100.28万股
- 最 低 2.45
- 昨 收 2.50
- 總市值 8.53亿
- 52周最高 5.8099
- 市盈率 靜 29.54
- 換手率 0.30%
- 52周最低 1.77
- 委 比 -99.11%
- 總股本 3.39亿
- 歷史最高 64.219
- 量 比 0.63
- 振 幅 3.80%
- 歷史最低 1.77
- 每 手 1
- 風險率 0.98%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多24小时环球政经要闻全览 | 5月19日
特朗普称将推迟对伊朗发动军事打击 美国总统特朗普当地时间5月18日在社交平台“真实社交”发文表示，在卡塔尔、沙特阿拉伯、阿联酋领导人要求下，他已下令19日不按原...
05-19 08:29
特朗普政府将仿制药纳入特朗普处方药计划
特朗普政府周一宣布，将把仿制药加入其直接面向消费者的药品销售网站TrumpRx，以扩大该平台的覆盖范围。该平台是政府降低美国处方药成本努力的核心举措。 ...
05-19 06:32
美股大行评级 | 阿里、京东、英伟达、思科等获多家大行上调目标价；Doximity、Dynatrace、Enovix、Wix.com等遭多家大行下调目标价
今日重点评级关注：HC Wainwright & Co.：维持Autolus Therapeutics"买入"评级，目标价从9美元升至10美元；Maxim Group：维持Rezolute"买入"评级，目标价从4美元升至10美元
05-15 10:49
Why Jim Cramer Says 'Pull The Trigger' On Chevron
Cramer recommends buying Chevron (CVX) due to good cash flow and limited downside, and waiting to buy Vertiv (VRT) on a decline. GoodRx (GDRX) reports mixed earnings, Sterling Infrastructure (STRL) can't be bought now after a 52% increase.
05-13 19:52
美股大行评级 | Arxis、Madison Air获多家大行首予买入评价！潜在涨幅441.87%！Caribou Biosciences获HC Wainwright & Co.升目标价至11美元，维持"买入"评级
今日重点评级关注：HC Wainwright & Co.：维持Caribou Biosciences"买入"评级，目标价从9美元升至11美元；康托·菲茨杰拉德：维持Artiva Biotherapeutics"超配"评级，目标价从10美元升至40美元
05-12 12:36
TD Cowen Maintains Buy on GoodRx Holdings, Raises Price Target to $4
TD Cowen analyst Charles Rhyee maintains GoodRx Holdings (NASDAQ:GDRX) with a Buy and raises the price target from $3 to $4.
05-12 02:24
Earnings Scheduled For May 6, 2026
Companies Reporting Before The Bell • Deluxe (NYSE:DLX) is expected to report q...
05-07 05:03
GoodRx Holdings Raises FY2026 Sales Guidance from $750.000M-$780.000M to $765.000M-$785.000M vs $764.443M Est
GoodRx Holdings (NASDAQ:GDRX) raises FY2026 sales outlook from $750.000 million-$780.000 million to $765.000 million-$785.000 million vs $764.443 million estimate.
05-07 04:47
GoodRx Holdings Q1 Adj. EPS $0.07, Inline, Sales $194.006M Beat $185.137M Estimate
GoodRx Holdings (NASDAQ:GDRX) reported quarterly earnings of $0.07 per share which met the analyst consensus estimate. This is a 22.22 percent decrease over earnings of $0.09 per share from the same period last year.
05-07 04:47
GoodRx Providing Access To Novo Nordisk's Ozempic Pill At $149/Month
GoodRx (NASDAQ:GDRX), the leading platform for prescription savings in the U.S., today announced that it is providing access to self-pay pricing for Novo Nordisk's Ozempic® pill (oral semaglutide), helping eligible
05-01 20:14
